GLP-1 weight-loss medications drive shift in plastic surgery patient profiles and procedural planning

Rapid weight loss induced by GLP-1 receptor agonists is creating a surge in demand for body contouring surgeries to address excess skin and tissue laxity. Plastic surgeons are adjusting clinical protocols to determine optimal timing for procedures, as rapid metabolic changes complicate traditional surgical planning.